Advertisement
News
Advertisement

RFID Chips for Breast Implants

Fri, 11/01/2013 - 10:45am
Business Wire

VeriTeQ Corporation, a provider of implantable medical device identification and radiation dose measurement technologies, has announced that it has delivered its first order of 2,000 Q Inside Safety Technology radio frequency identification microchips to breast implant partner Establishment Labs, S.A. VeriTeQ’s Q Inside Safety Technology is the Company’s unique device identifier, or UDI, for implantable and reusable medical device identification. EL’s Motiva Implant Matrix Ergonomix with VeriTeQ’s Q Inside Safety Technology is the world’s first externally identifiable breast implant.

By including VeriTeQ’s Q Inside Safety Technology, which is an FDA cleared radio frequency identification microchip that can be read safely from outside the body, in Motiva implants, physicians and patients will have access to a secure online database to retrieve implant-specific data such as serial number, manufacturer name, date of manufacture, lot number, volume, size, and other data. Q Inside Safety Technology also provides an extra level of protection to the patient in the event of a recall or other safety event.

The companies announced recently that EL received CE mark approval to market its Motiva Implant Matrix Ergonomix™ with VeriTeQ’s Q Inside Safety Technology. CE Mark approval enables EL to market its Motiva breast implants to patients in 28 countries in the European Union and fast track regulatory approvals in many countries in South America, Middle East and Asia.

Scott R. Silverman, Chairman and CEO of VeriTeQ, stated, “We are very pleased to help EL prepare for the upcoming international launch of their new implant, the Motiva Implant Matrix Ergonomix™ with VeriTeQ’s Q Inside Safety Technology, which we believe is a best-in-class product. We are gearing up to deliver additional microchips and readers to EL on an ongoing, monthly basis.”

According to the International Society of Aesthetic Plastic Surgery, the number of breast augmentation procedures performed worldwide in 2011 exceeded 1.2 million.

In September 2012, VeriTeQ entered into a development and supply agreement with EL, a global provider of breast implants under the Motiva Implant Matrix® brand name, to build next-generation breast implants that contain VeriTeQ’s Unique Device Identifier (“UDI”) called “Q Inside Safety Technology.” Under the terms of the agreement, VeriTeQ will receive payments from EL for the implantable microchips used in each implant, as well as external handheld readers.

For more information, visit www.veriteqcorp.com.

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading